Patrick G. Enright

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Michael Greco, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patrick G. Enright:

Form 4 holding Director

BioAge Labs, Inc.

Security class
Common Stock
Shares / value
1,710,589
Estimated value
$30,790,602
Report date
27 Sep 2024
Price
$18.00
Ownership
Longitude Venture Partners IV, L.P.
Form 4 holding Director, 10%+ Owner

Veradermics, Inc

Security class
Common Stock
Shares / value
2,053,474
Estimated value
Report date
05 Feb 2026
Price
Ownership
Indirect
Form 4 holding Director, 10%+ Owner

Veradermics, Inc

Security class
Stock Option (Right to Buy)
Shares / value
45,131
Estimated value
Report date
03 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Aptinyx Inc.

Security class
Stock Option (Right to Buy)
Shares / value
40,000
Estimated value
Report date
26 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

BioAge Labs, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
22,000
Estimated value
Report date
05 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Zenas BioPharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
18,500
Estimated value
Report date
10 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

BioAge Labs, Inc.

Security class
Series D Preferred Stock
Shares / value
0
Estimated value
Report date
27 Sep 2024
Price
Ownership
Longitude Venture Partners IV, L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Veradermics, Inc

Security class
Series B Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
05 Feb 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Veradermics, Inc

Security class
Series C Convertible Preferred Stock
Shares / value
0
Estimated value
Report date
05 Feb 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Patrick G. Enright

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .